Does LEUPROLIDE Cause Terminal state? 700 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 700 reports of Terminal state have been filed in association with LEUPROLIDE (Fensolvi). This represents 1.0% of all adverse event reports for LEUPROLIDE.
700
Reports of Terminal state with LEUPROLIDE
1.0%
of all LEUPROLIDE reports
125
Deaths
134
Hospitalizations
How Dangerous Is Terminal state From LEUPROLIDE?
Of the 700 reports, 125 (17.9%) resulted in death, 134 (19.1%) required hospitalization, and 76 (10.9%) were considered life-threatening.
Is Terminal state Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LEUPROLIDE. However, 700 reports have been filed with the FAERS database.
What Other Side Effects Does LEUPROLIDE Cause?
Hot flush (9,146)
Death (8,772)
Intercepted product preparation error (8,621)
Syringe issue (7,847)
Device leakage (5,861)
Wrong technique in product usage process (5,062)
Fatigue (4,805)
Injection site pain (4,678)
Prostatic specific antigen increased (2,432)
Asthenia (2,176)
What Other Drugs Cause Terminal state?
DENOSUMAB (563)
DARBEPOETIN ALFA (299)
CARBIDOPA\LEVODOPA (289)
ADALIMUMAB (253)
OCTREOTIDE (232)
ETANERCEPT (200)
RITUXIMAB (182)
ABATACEPT (181)
CLOZAPINE (180)
TOCILIZUMAB (179)
Which LEUPROLIDE Alternatives Have Lower Terminal state Risk?
LEUPROLIDE vs LEVALBUTEROL
LEUPROLIDE vs LEVAMISOLE
LEUPROLIDE vs LEVAQUIN
LEUPROLIDE vs LEVEMIR
LEUPROLIDE vs LEVETIRACETAM